DOI QR코드

DOI QR Code

The rare case of 46,XX testicular disorder of sex development carrying a heterozygous p.Arg92Trp variant in NR5A1

  • Lia Kim (Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Children's Hospital) ;
  • Hwa Young Kim (Department of Pediatrics, Seoul National University Bundang Hospital) ;
  • Jung Min Ko (Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Children's Hospital)
  • Received : 2022.10.11
  • Accepted : 2022.12.20
  • Published : 2022.12.31

Abstract

The 46,XX testicular disorder of sex development (DSD) is a rare condition in which 46,XX individuals develop testicular differentiation and virilization. Translocation of the sex-determining region Y (SRY) onto the X chromosome is the main cause of 46,XX testicular DSD, whereas dysregulation between pro-testis and pro-ovarian genes can induce SRY-negative 46,XX testicular DSD. Nuclear receptor subfamily 5 group A member 1 (NR5A1), a nuclear receptor transcription factor, plays an essential role in gonadal development in XY and XX embryos. Herein, we report the first Korean case of SRY-negative 46,XX testicular DSD with a heterozygous NR5A1 p.Arg92Trp variant. The patient presented with a small penis, bifid scrotum, and bilateral undescended testes. Whole exome sequencing revealed a heterozygous missense variant (c.274C>T) of NR5A1. Our case highlights that NR5A1 gene variants need to be considered important causative factors of SRY-negative non-syndromic 46,XX testicular DSD.

Keywords

References

  1. Grinspon RP, Rey RA. Disorders of sex development with testicular differentiation in SRY-negative 46,XX individuals: clinical and genetic aspects. Sex Dev 2016;10:1-11. https://doi.org/10.1159/000445088
  2. Grinspon RP, Rey RA. Molecular characterization of XX maleness. Int J Mol Sci 2019;20:6089.
  3. Bashamboo A, McElreavey K. Mechanism of sex determination in humans: insights from disorders of sex development. Sex Dev 2016;10:313-25. https://doi.org/10.1159/000452637
  4. Zenteno-Ruiz JC, Kofman-Alfaro S, Mendez JP. 46,XX sex reversal. Arch Med Res 2001;32:559-66. https://doi.org/10.1016/S0188-4409(01)00322-8
  5. Hughes IA, Houk C, Ahmed SF, Lee PA; Lawson Wilkins Pediatric Endocrine Society/European Society for Paediatric Endocrinology Consensus Group. Consensus statement on management of intersex disorders. J Pediatr Urol 2006;2:148-62. https://doi.org/10.1016/j.jpurol.2006.03.004
  6. Lambert S, Peycelon M, Samara-Boustani D, Hyon C, Dumeige L, Peuchmaur M, et al. SRY-negative 46,XX testicular/ovotesticular DSD: long-term outcomes and early blockade of gonadotropic axis. Clin Endocrinol (Oxf) 2021;94:667-76. https://doi.org/10.1111/cen.14389
  7. Suntharalingham JP, Buonocore F, Duncan AJ, Achermann JC. DAX-1 (NR0B1) and steroidogenic factor-1 (SF-1, NR5A1) in human disease. Best Pract Res Clin Endocrinol Metab 2015;29:607-19. https://doi.org/10.1016/j.beem.2015.07.004
  8. Kim JH, Kang E, Heo SH, Kim GH, Jang JH, Cho EH, et al. Diagnostic yield of targeted gene panel sequencing to identify the genetic etiology of disorders of sex development. Mol Cell Endocrinol 2017;444:19-25.
  9. Bashamboo A, Donohoue PA, Vilain E, Rojo S, Calvel P, Seneviratne SN, et al. A recurrent p.Arg92Trp variant in steroidogenic factor-1 (NR5A1) can act as a molecular switch in human sex development. Hum Mol Genet 2016;25:3446-53. Erratum in: Hum Mol Genet 2016;25:5286.
  10. Baetens D, Stoop H, Peelman F, Todeschini AL, Rosseel T, Coppieters F, et al. NR5A1 is a novel disease gene for 46,XX testicular and ovotesticular disorders of sex development. Genet Med 2017;19:367-76. https://doi.org/10.1038/gim.2016.118
  11. Igarashi M, Takasawa K, Hakoda A, Kanno J, Takada S, Miyado M, et al. Identical NR5A1 missense mutations in two unrelated 46,XX individuals with testicular tissues. Hum Mutat 2017;38:39-42. https://doi.org/10.1002/humu.23116
  12. Knarston IM, Robevska G, van den Bergen JA, Eggers S, Croft B, Yates J, et al. NR5A1 gene variants repress the ovarian-specific WNT signaling pathway in 46,XX disorders of sex development patients. Hum Mutat 2019;40:207-16.
  13. Saito-Hakoda A, Kanno J, Suzuki D, Kawashima S, Kamimura M, Hirano K, et al. A follow-up from infancy to puberty in a Japanese male with SRY-negative 46,XX testicular disorder of sex development carrying a p.Arg92Trp mutation in NR5A1. Sex Dev 2019;13:60-6. https://doi.org/10.1159/000496777
  14. Askari M, Rastari M, Seresht-Ahmadi M, McElreavey K, Bashamboo A, Razzaghy-Azar M, et al. A missense mutation in NR5A1 causing female to male sex reversal: a case report. Andrologia 2020;52:e13585.
  15. Swartz JM, Ciarlo R, Guo MH, Abrha A, Weaver B, Diamond DA, et al. A 46,XX ovotesticular disorder of sex development likely caused by a steroidogenic factor-1 (NR5A1) variant. Horm Res Paediatr 2017;87:191-5.
  16. Lee HJ, Yoon SC, Ko JM, Seong MW, Park SS, Choi JS, et al. Monochorionic dizygotic twins with discordant sex and confined blood chimerism. Eur J Pediatr 2014;173:1249-52. https://doi.org/10.1007/s00431-014-2312-8
  17. Domenice S, Machado AZ, Ferreira FM, Ferraz-de-Souza B, Lerario AM, Lin L, et al. Wide spectrum of NR5A1-related phenotypes in 46,XY and 46,XX individuals. Birth Defects Res C Embryo Today 2016;108:309-20.
  18. El-Khairi R, Martinez-Aguayo A, Ferraz-de-Souza B, Lin L, Achermann JC. Role of DAX-1 (NR0B1) and steroidogenic factor-1 (NR5A1) in human adrenal function. Endocr Dev 2011;20:38-46. https://doi.org/10.1159/000321213
  19. Guran T, Buonocore F, Saka N, Ozbek MN, Aycan Z, Bereket A, et al. Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort. J Clin Endocrinol Metab 2016;101:284-92. https://doi.org/10.1210/jc.2015-3250
  20. Biason-Lauber A, Schoenle EJ. Apparently normal ovarian differentiation in a prepubertal girl with transcriptionally inactive steroidogenic factor 1 (NR5A1/SF-1) and adrenocortical insufficiency. Am J Hum Genet 2000;67:1563-8. https://doi.org/10.1086/316893